Literature DB >> 12812950

MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism.

David D Martin1, Uwe Seeger, Michael B Ranke, Wolfgang Grodd.   

Abstract

To our knowledge, this is the first report of hypogonadotropic hypogonadism, or growth hormone deficiency, in a patient without non-Pallister-Hall syndrome who had hypothalamic hamartoma diagnosed on the basis of MR imaging and MR spectroscopy findings. On short-TE proton MR spectra, the N-acetylaspartate concentration in the hamartoma was lower than that in the thalamus but similar to that in the amygdala. However, myo-inositol concentration was elevated in the hamartoma compared with that in the amygdala and thalamus. This report stresses the advantages of short-TE spectroscopy and demonstrates that regional variations in spectra should be considered when reference structures are used.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812950      PMCID: PMC8149032     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

Review 1.  Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites.

Authors:  B D Ross
Journal:  NMR Biomed       Date:  1991-04       Impact factor: 4.044

Review 2.  Clinical applications of magnetic resonance spectroscopy.

Authors:  B Ross; T Michaelis
Journal:  Magn Reson Q       Date:  1994-12

Review 3.  The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma.

Authors:  K Arita; F Ikawa; K Kurisu; M Sumida; K Harada; T Uozumi; S Monden; J Yoshida; Y Nishi
Journal:  J Neurosurg       Date:  1999-08       Impact factor: 5.115

4.  [Hypothalamic hamartomas: control of seizures after partial removal in one case].

Authors:  I Pascual-Castroviejo; J H Moneo; J Viaño; J M García-Segura; M J Herguido; S I Pascual Pascual
Journal:  Rev Neurol       Date:  2000 Jul 16-31       Impact factor: 0.870

5.  "Pressure to laugh": an unusual epileptic symptom associated with small hypothalamic hamartomas.

Authors:  J W Sturm; F Andermann; S F Berkovic
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

6.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors.

Authors:  P Demaerel; K Johannik; P Van Hecke; C Van Ongeval; S Verellen; G Marchal; G Wilms; C Plets; J Goffin; F Van Calenbergh
Journal:  J Comput Assist Tomogr       Date:  1991 Jan-Feb       Impact factor: 1.826

7.  The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history.

Authors:  P Mahachoklertwattana; S L Kaplan; M M Grumbach
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

8.  Regional metabolic assessment of human brain during development by proton magnetic resonance spectroscopy in vivo and by high-performance liquid chromatography/gas chromatography in autopsy tissue.

Authors:  P S Hüppi; C Fusch; C Boesch; R Burri; E Bossi; M Amato; N Herschkowitz
Journal:  Pediatr Res       Date:  1995-02       Impact factor: 3.756

9.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

10.  Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases.

Authors:  Uwe Seeger; Uwe Klose; Irina Mader; Wolfgang Grodd; Thomas Nägele
Journal:  Magn Reson Med       Date:  2003-01       Impact factor: 4.668

View more
  7 in total

Review 1.  Hypothalamic hamartoma with epilepsy: Review of endocrine comorbidity.

Authors:  Victor S Harrison; Oliver Oatman; John F Kerrigan
Journal:  Epilepsia       Date:  2017-06       Impact factor: 5.864

2.  Evaluation of small hypothalamic hamartomas with 3D constructive interference in steady state (CISS) sequence.

Authors:  Masayuki Yamura; Toshinori Hirai; Yukunori Korogi; Mika Kitajima; Yoshiko Hayashida; Ichiro Ikushima; Fumio Endo; Yasuyuki Yamashita
Journal:  Neuroradiology       Date:  2005-02-25       Impact factor: 2.804

3.  Hypothalamic hamartomas: Correlation of MR imaging and spectroscopic findings with tumor glial content.

Authors:  D R Amstutz; S W Coons; J F Kerrigan; H L Rekate; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

4.  Pre- and postnatal MR imaging of hypothalamic hamartomas associated with arachnoid cysts.

Authors:  Timothy N Booth; Charles Timmons; Kenneth Shapiro; Nancy K Rollins
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

5.  Pituitary incidentalomas in paediatric age are different from those described in adulthood.

Authors:  Pedro Souteiro; Rúben Maia; Rita Santos-Silva; Rita Figueiredo; Carla Costa; Sandra Belo; Cíntia Castro-Correia; Davide Carvalho; Manuel Fontoura
Journal:  Pituitary       Date:  2019-04       Impact factor: 4.107

6.  Hypothalamic lipoma and growth hormone deficiency.

Authors:  Anne Rochtus; Joseph Vinckx; Francis de Zegher
Journal:  Int J Pediatr Endocrinol       Date:  2020-02-05

7.  MR imaging of hypothalamic hamartoma in a patient with gelastic seizures.

Authors:  Wan Ahmad Firdaus Wan Chek; Yong Guang Teh; Dian Noriza Eddy Suryono; Chiak Yot Ng; Selim Ahmed
Journal:  Radiol Case Rep       Date:  2021-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.